FDA Approves HRT Label Changes - Top-Institutions - MDSpire

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

  • By

  • Kathryn Wighton

  • February 12, 2026

  • 2 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Gynecology
    • Women's Health

  • #2

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Obstetrics and Gynecology
    • Endocrinology
    • Women's Health

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Gynecology
    • Endocrinology
    • Women's Health

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Gynecology
    • Women's Health

  • #5

    Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of Medicine

    Chicago, IL

    Key Differentiators

    • Obstetrics and Gynecology
    • Endocrinology
    • Women's Health

Original Source(s)

FDA Approves HRT Label Changes

  • by Kathryn Wighton

  • February 12, 2026

Related Content

FDA Approves Gedatolisib in Breast Cancer

In VIKTORIA-1, gedatolisib-containing regimens resulted in longer median progression-free survival than fulvestrant alone.

Editorial: Transitioning through menopause: contraceptive choices and sexual well-being

Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study